Therefore, silencing SOAT1 may significantly reduce the survival rate of glioma cells under RT by increasing the level of lipid peroxidation, whereas SLC40A1 OE and DFO, increases the survival rate of glioma cells by reducing the level of lipid peroxidation. The gene discussed is SOAT1; the disease is central nervous system cancer.